DanioLabs Ltd. Appoints Dr. Nigel Blackburn As Head Of Clinical Development
By Suvarna Bhatt
San Francisco, March 8 (BioSpace) – DanioLabs, a Cambridge, United Kingdom based therapeutics company which focuses on neurology and ophthamology has appointed Dr Nigel Blackburn as Head of Clinical Development.
Nigel joins DanioLabs from Roche.
Contact Suvarna Bhatt at sbhatt@biospace.com.